![]() Invited Symposium: Stroke/Cerebral Vasospasm |
Results Effect of hemolysate on tyrosine phosphorylation
The effect of hemolysate on [Ca2+]i was concentration-dependent (Fig. 3).
In the absence of extracellular Ca2+ (buffer also contained 1.0 mM EGTA), the addition of 10% hemolysate raised [Ca2+]i to a peak level and a sustained plateau, significantly less than the peak and plateau [Ca2+]i responses of the cells to hemolysate in the presence of extracellular Ca2+ (Fig. 4).
These data indicate that [Ca2+]i entry may be an important component in both peak and plateau [Ca2+]i responses to hemolysate. Effects of tyrosine kinase inhibitors on hemolysate-induced [Ca2+]i M genistein for 5 min did not change the resting level, however, resulted in a significant reduction of the [Ca2+]i response, both peak and plateau responses, to hemolysate (Fig. 5).
Increasing the genistein concentration to 100 M further reduced the response to hemolysate (Fig. 6).
Tyrphostin A51, a synthetic tyrosine kinase inhibitor that is structurally different from genistein, produced a similar inhibitory effect to the [Ca2+]i response to hemolysate (Fig. 7, Fig. 8).
To test the specificity of those tyrosine kinase inhibitors, tyrphostin A1, an inactive analogue of tyrphostins, was used in a similar fashion. Tyrphostin A1 (30 M) did not alter the [Ca2+]i response evoked by hemolysate. To test the involvement of other protein kinases, staurosporine, a PKC inhibitor which is a relatively non-specific inhibitor of protein kinases, was applied. Staurosporine (100 nM) pretreatment of cells for 5 min, failed to markedly inhibit the initial [Ca2+]i peak response to hemolysate, however, it reduced significantly the sustained plateau [Ca2+]i level (Fig. 9).
Effects of tyrosine kinase inhibitors on fractionated hemolysate-induced [Ca2+]i
The effect of the small molecular weight fraction of hemolysate on [Ca2+]i was also dose dependent (Fig. 11).
In contrast, the large molecular weight fraction of hemolysate (>10 kD) did not evoke a marked response in [Ca2+]i (Fig. 12).
Genistein (30 M) pretreatment for 5 min inhibited both the initial peak and the sustained phase of [Ca2+]i evoked by the small molecular weight hemolysate fraction (Fig. 13).
Increasing the genistein concentration to 100 M further reduced the [Ca2+]i response to the small molecular weight fraction (Fig. 14).
A similar inhibitory response was obtained by tyrphostin A51, significantly reducing both the initial peak and the plateau [Ca2+]i responses to small molecular weight hemolysate fraction (Fig. 15, Fig. 16).
The [Ca2+]i peak response to a 10% concentration of the large molecule fraction was nearly completely inhibited by genistein or tyrophostin A51.
| Discussion Board | Next Page | Your Symposium | |
||||||||||
Iwabuchi, S MD; Zhang, J MD PhD.; Aoki, K MD.; Marton, L PhD.; Kimura, H MD.; Samejima, H MD; (1998). Tyrosine Kinase In Cerebral Vasospasm. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Invited Symposium. Available at URL http://www.mcmaster.ca/inabis98/zhang/iwabuchi0452/index.html | |||||||||||
© 1998 Author(s) Hold Copyright |